A case–control study comparing the age-specific association between the APOE genotype and AD in the CSF of more than a thousand AD cases reported that the highest impact of APOE4 on AD risk was between the ages of 65 and 70 [523]. This evidence concerns the gene APOE and Alzheimer disease.